Scholarly Index
Rita Nanda
University of Chicago; 16,541 total citations; 401 total publications; best world rank #101
University of Chicago
16,541Total citations
401Total publications
56H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 763 | US 380 | 98.39 |
| Advanced Breast Cancer Therapies | Lifetime | 189 | US 92 | 98.40 |
| HER2/EGFR in Cancer Research | Lifetime | 511 | US 235 | 97.91 |
| Breast Cancer Treatment Studies | Lifetime | 851 | US 378 | 97.64 |
| PARP inhibition in cancer therapy | Lifetime | 719 | US 310 | 92.65 |
| Breast Cancer Treatment Studies | 2021-2025 | 130 | US 48 | 98.36 |
| Advanced Breast Cancer Therapies | 2021-2025 | 101 | US 36 | 98.28 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 602 | US 225 | 97.69 |
| HER2/EGFR in Cancer Research | 2021-2025 | 134 | US 48 | 98.02 |
| Cancer Genomics and Diagnostics | 2021-2025 | 952 | US 406 | 94.58 |
| Cancer Treatment and Pharmacology | 2021-2025 | 309 | US 111 | 93.86 |
| Cancer Cells and Metastasis | 2021-2025 | 445 | US 120 | 89.51 |
| PARP inhibition in cancer therapy | 2021-2025 | 454 | US 173 | 87.78 |
| Neutropenia and Cancer Infections | 2021-2025 | 876 | US 296 | 68.84 |